Nicotinamide

suppression of lymphocyte transformation with a component identified in human transfer factor

D. R. Burger, Arthur Vandenbark, D. Daves, W. A. Anderson, R. M. Vetto, P. Finke

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

The component in human transfer factor (TF) (Fraction IV, from exclusion chromatography on Sephadex G 25) responsible for suppression of antigen induced lymphocyte transformation was previously identified as nicotinamide. Commercially available nicotinamide was subsequently shown to produce suppression of antigen induced responses in vitro previously observed with TF Fraction IV. Nicotinamide was found to be nontoxic at the highest concentrations employed (10 -2 M) and suppressive over a relatively broad range (10 -5 to 10 -2 M). The suppression appeared to be related to the magnitude of antigen or mitogen induced transformation and was apparent even when nicotinamide was added as late as 48 hr after stimulant addition.

Original languageEnglish (US)
Pages (from-to)797-801
Number of pages5
JournalJournal of Immunology
Volume117
Issue number3
StatePublished - 1976
Externally publishedYes

Fingerprint

Transfer Factor
Niacinamide
Lymphocyte Activation
Antigens
Mitogens
Gel Chromatography

ASJC Scopus subject areas

  • Immunology

Cite this

Burger, D. R., Vandenbark, A., Daves, D., Anderson, W. A., Vetto, R. M., & Finke, P. (1976). Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor. Journal of Immunology, 117(3), 797-801.

Nicotinamide : suppression of lymphocyte transformation with a component identified in human transfer factor. / Burger, D. R.; Vandenbark, Arthur; Daves, D.; Anderson, W. A.; Vetto, R. M.; Finke, P.

In: Journal of Immunology, Vol. 117, No. 3, 1976, p. 797-801.

Research output: Contribution to journalArticle

Burger, DR, Vandenbark, A, Daves, D, Anderson, WA, Vetto, RM & Finke, P 1976, 'Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor', Journal of Immunology, vol. 117, no. 3, pp. 797-801.
Burger, D. R. ; Vandenbark, Arthur ; Daves, D. ; Anderson, W. A. ; Vetto, R. M. ; Finke, P. / Nicotinamide : suppression of lymphocyte transformation with a component identified in human transfer factor. In: Journal of Immunology. 1976 ; Vol. 117, No. 3. pp. 797-801.
@article{dc6797c5f64f4522a0a0b34991e6bc1a,
title = "Nicotinamide: suppression of lymphocyte transformation with a component identified in human transfer factor",
abstract = "The component in human transfer factor (TF) (Fraction IV, from exclusion chromatography on Sephadex G 25) responsible for suppression of antigen induced lymphocyte transformation was previously identified as nicotinamide. Commercially available nicotinamide was subsequently shown to produce suppression of antigen induced responses in vitro previously observed with TF Fraction IV. Nicotinamide was found to be nontoxic at the highest concentrations employed (10 -2 M) and suppressive over a relatively broad range (10 -5 to 10 -2 M). The suppression appeared to be related to the magnitude of antigen or mitogen induced transformation and was apparent even when nicotinamide was added as late as 48 hr after stimulant addition.",
author = "Burger, {D. R.} and Arthur Vandenbark and D. Daves and Anderson, {W. A.} and Vetto, {R. M.} and P. Finke",
year = "1976",
language = "English (US)",
volume = "117",
pages = "797--801",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Nicotinamide

T2 - suppression of lymphocyte transformation with a component identified in human transfer factor

AU - Burger, D. R.

AU - Vandenbark, Arthur

AU - Daves, D.

AU - Anderson, W. A.

AU - Vetto, R. M.

AU - Finke, P.

PY - 1976

Y1 - 1976

N2 - The component in human transfer factor (TF) (Fraction IV, from exclusion chromatography on Sephadex G 25) responsible for suppression of antigen induced lymphocyte transformation was previously identified as nicotinamide. Commercially available nicotinamide was subsequently shown to produce suppression of antigen induced responses in vitro previously observed with TF Fraction IV. Nicotinamide was found to be nontoxic at the highest concentrations employed (10 -2 M) and suppressive over a relatively broad range (10 -5 to 10 -2 M). The suppression appeared to be related to the magnitude of antigen or mitogen induced transformation and was apparent even when nicotinamide was added as late as 48 hr after stimulant addition.

AB - The component in human transfer factor (TF) (Fraction IV, from exclusion chromatography on Sephadex G 25) responsible for suppression of antigen induced lymphocyte transformation was previously identified as nicotinamide. Commercially available nicotinamide was subsequently shown to produce suppression of antigen induced responses in vitro previously observed with TF Fraction IV. Nicotinamide was found to be nontoxic at the highest concentrations employed (10 -2 M) and suppressive over a relatively broad range (10 -5 to 10 -2 M). The suppression appeared to be related to the magnitude of antigen or mitogen induced transformation and was apparent even when nicotinamide was added as late as 48 hr after stimulant addition.

UR - http://www.scopus.com/inward/record.url?scp=0017163142&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017163142&partnerID=8YFLogxK

M3 - Article

VL - 117

SP - 797

EP - 801

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -